vivo activation p53 pathway small-molecule antagonists mdm2
mdm2 binds p53 tumor suppressor protein high affinity negatively modulates transcriptional activity stability overexpression mdm2 found many human tumors effectively impairs p53 function inhibition mdm2-p53 interaction can stabilize p53 may offer novel strategy cancer therapy identify potent selective small-molecule antagonists mdm2 confirm mode action crystal structures complexes compounds bind mdm2 p53-binding pocket activate p53 pathway cancer cells leading cell cycle arrest apoptosis growth inhibition human tumor xenografts nude mice
